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Abstract 
Anti-malarial drugs are primary weapons for reducing Plasmodium transmission in human populations.  
Successful drugs have been highly efficacious and inexpensive to synthetically manufacture.  Emergence 
of resistant parasites reduces the lifespan of each drug that is developed and deployed.  Currently, the 
most effective anti-malarial is artemisinin (AN), which is extracted from the leaves of Artemisia annua.  
Because of its poor pharmacokinetic properties and prudent efforts to curtail emergence of resistance, 
AN is prescribed only in combination with other anti-malarials composing an Artemisinin Combination 
Therapy (ACT).  Low yield in the plant and the added cost of secondary anti-malarials in the ACT, make 
AN in the developing world a costly treatment.  Here we show that dried leaves of A. annua 
administered orally are more effective at killing malaria parasites than a comparable dose of purified 
drug in a rodent malaria model (P. chabaudi).  A single dose of whole plant (WP) A. annua containing 24 
mg/kg AN clears 99% of parasites, where a comparable dose of pure drug has half that effect.  This is 
consistent with findings that blood levels of AN are 40 times greater in mice receiving WP versus those 
given pure drug.  We hypothesize that in addition to increasing bioavailability of AN, administration of 
WP alone may constitute a combination therapy because it contains other anti-malarial compounds that 
have been shown to synergize with AN.  Inexpensive, efficacious, and resilient treatment for malaria 
based upon WP A. annua that can be grown and processed locally would be an effective addition to the 
global effort to reduce malaria morbidity and mortality. 
